Meeting
2020 Gastrointestinal Cancers Symposium
Declining use of red blood cell transfusions for gastrointestinal cancer surgery: A population-based analysis.
Authors
Jesse Zuckerman
Division of General Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada
Jesse Zuckerman , Natalie Coburn , Jeannie Callum , Alyson Mahar , Victoria Zuk , Yulia Lin , Robin McLeod , Alexis F. Turgeon , Emily Pearsall , Guillaume Martel , Julie Hallet
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers
Track
Esophageal and Gastric Cancer,Other GI Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 802)
Abstract #
802
Poster Bd #
J6
Abstract Disclosures
Similar Posters
Poster
2021 Gastrointestinal Cancers Symposium
Association of perioperative red blood cell transfusions with all-cause and cancer-specific death in patients undergoing surgery for gastrointestinal cancer.
First Author: Jesse Zuckerman
Poster
2024 ASCO Annual Meeting
Clinical benefit of luspatercept treatment (tx) in transfusion-dependent (TD), erythropoiesis-stimulating agent (ESA)–naive patients (pts) with very low-, low- or intermediate-risk myelodysplastic syndromes (MDS) in the COMMANDS trial.
First Author: Amer Methqal Zeidan
Poster
2024 ASCO Annual Meeting
Evaluating the potential of micronuclei DNA from erythrocytes for early detection or recurrence risk prediction of colorectal cancer.
First Author: Xingyun Yao
Poster
2024 ASCO Annual Meeting
Impact of pacritinib on symptoms in with thrombocytopenia and myelofibrosis who require red blood cell transfusion.
First Author: Stephen Oh